Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Go to Funding Search

Key Information

Due Date: May 7, 2026


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: $581,371


Funding Type: Grant


Match Required: No


Status: Posted


Contact Info: grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Overview

This is information about a funding opportunity for clinical neuroscience research on Substance Use Disorders (SUD), namely the (R61/R33 Clinical Trial Optional) Exploratory Clinical Neuroscience Research grant. The grant is offered through a Phased Innovation Award model, aimed specifically at studies that are exploratory and developmental in their nature. The research focus should be on understanding the neurobiological mechanisms that underpin SUD, and should also delve into the basics of brain function as it relates to substance use. One particular attribute of this grant is that it is designed to fund projects that need more budget than the R21 mechanism allows, which is a similar but separate funding opportunity for neuroscience research on drug abuse, also with optional clinical trials.
Show More

Key Dates

Open Date: April 10, 2023


Application Due Date: May 7, 2026


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • State governments
  • County governments
  • City, village or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Private institutions of higher education
  • Small businesses

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.